Policies

Below are UNMC policies relating to biosafety (click policy number to view in PDF format):

• IBC-01: Autoclave Operation and Safety
• IBC-02: Biological Safety Cabinet Certification
• IBC-03: Biological Safety Cabinet Operation
• IBC-04: Biological Spill Clean-Up
• IBC-05: Biohazardous Waste Disposal
• IBC-06: Biosafety Training Program
• IBC-07: Centrifuge Safe Operation
• IBC-08: IBC Application & Review Process: New Protocols (General)
• IBC-09: IBC Application & Review Process: New Protocols Utilizing Select Agents
• IBC-10: IBC Application & Review Process: New Protocols Involving Human Gene Transfer
• IBC-11: IBC Laboratory Inspection Process
• IBC-12: IBC Review Process for Previously Approved Protocols
• IBC-13: Immunization Policy for Research Using Vaccinia Virus
• IBC-14: Paraformaldehyde Room and Biological Safety Cabinet Decontamination
• IBC-17: Laboratory Decommissioning
• IBC-19: Laboratory Commissioning, BL-2
• IBC-20: Laboratory Commissioning, BL-3
• IBC-24: Reporting Adverse Event
• IBC-29: Personnel Access for BL-3 Containment
• IBC-30: Category A High Consequence Pathogens
• IBC-32: Federal Permits for Shipment of Human Pathogens
• IBC-33: Off-site Laboratories
• IBC-34: Biosafety Risk Factor Assessment Process to Determine Appropriate Containment
• IBC-35: Registration Process for the Use of Exempt Recombinant DNA
• IBC-36: Visiting Scientist and Student for Access
• IBC-37: Serum Banking
• IBC-38: Personal Protective Equipment
• IBC-39: Pest Management
• IBC-40: Removal of Materials from the ABSL-3 or BSL-3 Laboratory
• IBC-41: Safe Handling and Disposal of Sharps
• IBC-42: Dual Use Research of Concern (DURC) Oversight
• IBC-43: Use of Human and Nonhuman Primate Tissues, Cells, and Cell Lines
• IBC-44: Allegations of Noncompliance